Balyasny Asset Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,970	Closed	-$106K	–	1645
2018 Q3	$106K	Buy	+12,970	New	+$106K	﹤0.01%	1383
2018 Q1	–	Sell	-168,500	Closed	-$2.11M	–	2107
2017 Q4	$2.11M	Buy	168,500 +59,916	+55%	+$750K	0.01%	908
2017 Q3	$908K	Buy	+108,584	New	+$908K	﹤0.01%	993